Alzheimer’s APOE4 Genetic Risk Targeted in Promising Trial Preliminary results offer hope that gene therapy can protect people [...] By digitalstudios|2022-12-02T21:55:07+00:00December 2, 2022|3rd Party Pharmaceutical Industry News|Comments Off on Alzheimer’s APOE4 Genetic Risk Targeted in Promising Trial Read More